These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30640942)

  • 1. Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
    Hugdahl E; Bachmann IM; Schuster C; Ladstein RG; Akslen LA
    PLoS One; 2019; 14(1):e0210399. PubMed ID: 30640942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
    Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
    Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
    Straume O; Akslen LA
    Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.
    Bachmann IM; Ladstein RG; Straume O; Naumov GN; Akslen LA
    BMC Cancer; 2008 Dec; 8():362. PubMed ID: 19061491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. uPAR
    Porcelli L; Guida M; De Summa S; Di Fonte R; De Risi I; Garofoli M; Caputo M; Negri A; Strippoli S; Serratì S; Azzariti A
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
    Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
    J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    Mod Pathol; 2014 Mar; 27(3):396-401. PubMed ID: 24030749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
    Rofstad EK; Rasmussen H; Galappathi K; Mathiesen B; Nilsen K; Graff BA
    Cancer Res; 2002 Mar; 62(6):1847-53. PubMed ID: 11912164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
    Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
    Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma.
    Jonjic N; Zamolo G; Stifter S; Fuckar D; Gruber F; Sasso F; Rizzardi C; Melato M
    Clin Exp Dermatol; 2003 May; 28(3):310-4. PubMed ID: 12780721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis correlates with metastasis in melanoma.
    Neitzel LT; Neitzel CD; Magee KL; Malafa MP
    Ann Surg Oncol; 1999; 6(1):70-4. PubMed ID: 10030417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1.
    Sivridis E; Koukourakis MI; Mendrinos SE; Karpouzis A; Fiska A; Kouskoukis C; Giatromanolaki A
    Melanoma Res; 2011 Jun; 21(3):188-95. PubMed ID: 21537144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J; Rabbani SA; Shibata HR; Brodt P
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
    Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
    Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
    Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
    J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.